Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 3/20 | 0.46 |
| ▸ | CSF1R | P07333 | 16/20 | 0.44 |
| ▸ | PDGFRA | P16234 | 7/20 | 0.44 |
| ▸ | PDGFRB | P09619 | 6/20 | 0.44 |
| ▸ | MET | P08581 | 2/20 | 0.44 |
| ▸ | FLT3 | P36888 | 1/20 | 0.44 |
| ▸ | KIT | P10721 | 8/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31352529 | 0.92 | KDR (0.45) | KDRCSF1RPDGFRAPDGFRBMET | |
| SCHEMBL31352525 | 0.91 | CSF1R (0.53) | KDRCSF1RPDGFRAPDGFRBMET | |
| SCHEMBL31352596 | 0.91 | CSF1R (0.46) | KDRCSF1RPDGFRAPDGFRBMET | |
| SCHEMBL31352543 | 0.90 | SMN1; SMN2 (0.50) | KDRCSF1RPDGFRAPDGFRBMET | |
| SCHEMBL31352656 | 0.90 | RAB9A (0.49) | KDRCSF1RPDGFRAPDGFRBMET | |
| SCHEMBL31352532 | 0.87 | KDR (0.47) | KDRCSF1RPDGFRAPDGFRBMET | |
| SCHEMBL31352501 | 0.87 | CSF1R (0.48) | KDRCSF1RPDGFRAPDGFRBMET | |
| SCHEMBL31352535 | 0.87 | CSF1R (0.45) | KDRCSF1RPDGFRAPDGFRBMET | |
| SCHEMBL31352663 | 0.86 | CSF1R (0.45) | KDRCSF1RPDGFRAPDGFRBMET | |
| SCHEMBL31352499 | 0.83 | CSF1R (0.45) | KDRCSF1RPDGFRAPDGFRBMET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025021943-A1 | QUINAZOLINONE, BENZOXAZINONE AND BENZOXAZEPINONE DERIVATIVES AS PROTEIN KINASE INHIBITORS | NEURALIS (BE) | 2025-01-30 | — | — | WO | disclosed |